The effectiveness of low-dose aspirin (LDA) in reducing adverse pregnancy outcomes
Annual results as of 31.12.2022 and outlook 2023 – Biotech Investments
Vitruvia Medical AG / Key word(s): Annual Results/Annual Report Vitruvia Medical AG: Annual results as of 31.12.2022 and outlook 2023 25-Jun-2023 / 09:59 CET/CEST Disclosure